Login
Join
Login
Join
Login
Join
Financings – Cont. from Vital Signs 11/14/23
more info
We had several financings that didnt make the 11/14 edition of Vital Signs.

VectorY Therapeutics – a biotech company developing antibody therapies to treat neurodegenerative diseases, raised a $138M Series A. (Amsterdam, Netherlands)

Needed – a company that develops nutrition products for prenatal care, raised $14M. (LA, CA)
Facebook
Twitter
LinkedIn
Categories
Archives

Recent Posts

Tax Strategies – QSBS

There are three things that create drag on investment returns: 1) Losses 2) Taxes 3)…

Financings – Cont. from Vital Signs 12/1/23

We had several financings that didnt make the 12/1 edition of Vital Signs. Biolexis Therapeutics…

Luck

When a startup or an investment is successful, it’s more likely that we attribute the…

AngelMD is a large and growing healthcare innovation community connecting clinicians, startups, investors, Industry and other stakeholders.

Linkedin Facebook-f Youtube Twitter

About

Clinicians

Partners

Startups

Investors

AngelMD is a large and growing healthcare innovation community centered around clinician & startups with tools & education for both.

Linkedin Facebook-f Youtube Twitter

About

Clinicians

Partners

Startups

Investors

Top Cities / Regions - US

  • Seattle
  • Bay Area
  • Southern California
  • Salt Lake City
  • Denver / Boulder / Fort Collins
  • Chicago
  • Cleveland
  • Dallas
  • Austin
  • Houston
  • Atlanta
  • Florida
  • Boston
  • New York

Top International Regions

  • Canada
  • UK
  • Germany
  • Israel
  • MENA
  • India
  • Japan
  • Singapore
  • South Korea

Most Active Specialties

  • Dentistry
  • Orthopedics
  • Urology
  • Cardiology
  • ENT
  • Plastic Surgery
  • Gastroenterology
  • Oncology
  • Radiology
  • Ophthalmology
  • Pediatrics
  • Elder Care